Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 65360

105 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 29, 2013
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

105 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 105

Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL

D-692-2013
Recall number
D-692-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5911 exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 2 of 105

Acepromazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-693-2013
Recall number
D-693-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0112 exp 08/31/13

Distribution pattern

Nationwide and PR

drug · product 3 of 105

Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL

D-694-2013
Recall number
D-694-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5631 exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 4 of 105

Alprostadil 2000 mcg/ml, compounded by Olympia Pharmacy, Orlando, FL

D-695-2013
Recall number
D-695-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
5

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5008 exp 12/31/13, K5030 Exp. 11/30/13, A5716 Exp. 8/31/13, C5121 Exp 9/12/13, and C5208 Exp 9/7/13

Distribution pattern

Nationwide and PR

drug · product 5 of 105

Altrenogest 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-696-2013
Recall number
D-696-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5012 exp. 11/30/13

Distribution pattern

Nationwide and PR

drug · product 6 of 105

Amikacin Sulfate 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-697-2013
Recall number
D-697-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5501 Exp 8/5/13 and B3025 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 7 of 105

Aminocaproic Acid 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-698-2013
Recall number
D-698-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B3727 Exp 8/7/13

Distribution pattern

Nationwide and PR

drug · product 8 of 105

Aminocaproic Acid 0.5mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL

D-699-2013
Recall number
D-699-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5505 Exp. 08/06/13

Distribution pattern

Nationwide and PR

drug · product 9 of 105

Aminophylline 2.5% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-700-2013
Recall number
D-700-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5630 Exp. 12/31/13

Distribution pattern

Nationwide and PR

drug · product 10 of 105

Atipamezole 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-701-2013
Recall number
D-701-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L3628 Exp 12/31/13, B5306 Exp 8/6/13, and C3120 Exp 9/20/13

Distribution pattern

Nationwide and PR

drug · product 11 of 105

Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-702-2013
Recall number
D-702-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5115 Exp 9/11/13

Distribution pattern

Nationwide and PR

drug · product 12 of 105

Beta Alanine 100 mg/ml / l-carnosine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-703-2013
Recall number
D-703-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

K4419 Exp 12/14/13

Distribution pattern

Nationwide and PR

drug · product 13 of 105

Betamethasone Sodium Phosphate 12 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-704-2013
Recall number
D-704-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5719 Exp 6/7/13

Distribution pattern

Nationwide and PR

drug · product 14 of 105

Betamethasone Phosphate/Acetate 6 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-705-2013
Recall number
D-705-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5810 exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 15 of 105

Bi mix, compounded by Olympia Pharmacy, Orlando, FL

D-706-2013
Recall number
D-706-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
4

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5028 Exp 6/2/13, B5011 exp 6/1/13, C4112 Exp 6/1/13, and C4208 Exp 6/20/13

Distribution pattern

Nationwide and PR

drug · product 16 of 105

BNP/Dexamethasone Eye Ointment, compounded by Olympia Pharmacy, Orlando, FL

D-707-2013
Recall number
D-707-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5119 exp 10/31/13

Distribution pattern

Nationwide and PR

drug · product 17 of 105

Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-708-2013
Recall number
D-708-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B3727 Exp 12/27/13, C5511 Exp 9/5/13, and L5312 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 18 of 105

Caco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-709-2013
Recall number
D-709-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5610 exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 19 of 105

Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL

D-710-2013
Recall number
D-710-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5914 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 20 of 105

Cal-Phos 1000 Injection, compounded by Olympia Pharmacy, Orlando, FL

D-711-2013
Recall number
D-711-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5211 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 21 of 105

Ceftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-712-2013
Recall number
D-712-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

K5520 Exp 11/23/13

Distribution pattern

Nationwide and PR

drug · product 22 of 105

Chlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-713-2013
Recall number
D-713-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5812 Exp 9/8/13 and L4317 Exp 6/30/13

Distribution pattern

Nationwide and PR

drug · product 23 of 105

Clenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-714-2013
Recall number
D-714-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A0107 Exp 01/31/14

Distribution pattern

Nationwide and PR

drug · product 24 of 105

Cre-O-Pan Injection, compounded by Olympia Pharmacy, Orlando, FL

D-715-2013
Recall number
D-715-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A3021 Exp 6/2/13

Distribution pattern

Nationwide and PR

drug · product 25 of 105

Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL

D-716-2013
Recall number
D-716-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A3021 Exp 6/2/13 and L5011 exp 12/11/13

Distribution pattern

Nationwide and PR

drug · product 26 of 105

Detomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-717-2013
Recall number
D-717-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5505 Exp 9/5/13 and C5107 Exp 9/7/13

Distribution pattern

Nationwide and PR

drug · product 27 of 105

Detomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Orlando, FL

D-718-2013
Recall number
D-718-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5125 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 28 of 105

Dexamethasone Sodium Phosphate 6 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-719-2013
Recall number
D-719-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5504 Exp 8/31/13

Distribution pattern

Nationwide and PR

drug · product 29 of 105

Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-720-2013
Recall number
D-720-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

I5406 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 30 of 105

Dextrose 50% Solution, compounded by Olympia Pharmacy, Orlando, FL

D-721-2013
Recall number
D-721-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5414 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 31 of 105

Diclazuril 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-722-2013
Recall number
D-722-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5014 Exp 8/14/13

Distribution pattern

Nationwide and PR

drug · product 32 of 105

Diphenhydramine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-723-2013
Recall number
D-723-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A3804 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 33 of 105

Disodium EDTA Injection, compounded by Olympia Pharmacy, Orlando, FL

D-724-2013
Recall number
D-724-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5616 Exp 7/31/13

Distribution pattern

Nationwide and PR

drug · product 34 of 105

Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-725-2013
Recall number
D-725-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0105 Exp 8/19/13

Distribution pattern

Nationwide and PR

drug · product 35 of 105

Enrofloxacin 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-726-2013
Recall number
D-726-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5011 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 36 of 105

Estradiol Cypionate 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-727-2013
Recall number
D-727-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5026 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 37 of 105

Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-728-2013
Recall number
D-728-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C51212 Exp 8/12/13

Distribution pattern

Nationwide and PR

drug · product 38 of 105

Fluphenazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-729-2013
Recall number
D-729-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5428 Exp 9/4/13

Distribution pattern

Nationwide and PR

drug · product 39 of 105

Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-730-2013
Recall number
D-730-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5029 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 40 of 105

Gaba 50 mg/Mag Sulfate 50 mg/Taurine/Theanine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-731-2013
Recall number
D-731-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C3729 Exp 9/7/13

Distribution pattern

Nationwide and PR

drug · product 41 of 105

Gentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-732-2013
Recall number
D-732-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5308 Exp 6/30/13

Distribution pattern

Nationwide and PR

drug · product 42 of 105

Gentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-733-2013
Recall number
D-733-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5014 Exp 8/13/13 and C3913 Exp 9/9/13

Distribution pattern

Nationwide and PR

drug · product 43 of 105

Gentamicin 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-734-2013
Recall number
D-734-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L3419 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 44 of 105

Gentamicin Sulfate 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-735-2013
Recall number
D-735-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5125 Exp 8/25/13

Distribution pattern

Nationwide and PR

drug · product 45 of 105

Glutathione 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-736-2013
Recall number
D-736-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5110 Exp 9/11/13

Distribution pattern

Nationwide and PR

drug · product 46 of 105

Guanabenz 8 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-737-2013
Recall number
D-737-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C3621 Exp 9/21/13, L3618 Exp 10/31/13, and A0224 Exp 6/30/13

Distribution pattern

Nationwide and PR

drug · product 47 of 105

Guanabenz 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-738-2013
Recall number
D-738-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A0422 Exp 7/31/13

Distribution pattern

Nationwide and PR

drug · product 48 of 105

HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL

D-739-2013
Recall number
D-739-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C0321 Exp 9/3/13 and B5627 6/4/13

Distribution pattern

Nationwide and PR

drug · product 49 of 105

HCG 125iu/0.25ml (550iu/ml), 3500iu and 10,000iu, compounded by Olympia Pharmacy, Orlando, FL

D-740-2013
Recall number
D-740-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

500iu Lot A3504 Exp 8/31/13 3500iu Lot C3105 Exp 9/5/13 10000 iu Lot C3611 Exp 9/6/13

Distribution pattern

Nationwide and PR

drug · product 50 of 105

Hippiron 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-741-2013
Recall number
D-741-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5006 Exp 8/6/13 and L5807 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 51 of 105

Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-742-2013
Recall number
D-742-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5703 Exp 11/30/2013

Distribution pattern

Nationwide and PR

drug · product 52 of 105

Iodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL

D-743-2013
Recall number
D-743-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C51501 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 53 of 105

ITPP 50 mg/ml DMG 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-744-2013
Recall number
D-744-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A3113 Exp 7/1/13 and A3401 Exp 2/1/14

Distribution pattern

Nationwide and PR

drug · product 54 of 105

Ketamine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-745-2013
Recall number
D-745-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B3411 Exp 8/11/13

Distribution pattern

Nationwide and PR

drug · product 55 of 105

Ketoprofen Solution 10% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-746-2013
Recall number
D-746-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5122 Exp 9/22/13

Distribution pattern

Nationwide and PR

drug · product 56 of 105

L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-747-2013
Recall number
D-747-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0005 Exp 8/5/13

Distribution pattern

Nationwide and PR

drug · product 57 of 105

Lipotoxin Injection, compounded by Olympia Pharmacy, Orlando, FL

D-748-2013
Recall number
D-748-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A3121 Exp 9/30/12

Distribution pattern

Nationwide and PR

drug · product 58 of 105

Lisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-749-2013
Recall number
D-749-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5028 Exp 6/2/13

Distribution pattern

Nationwide and PR

drug · product 59 of 105

Medetomidine 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-750-2013
Recall number
D-750-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5714 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 60 of 105

Medroxyprogesterone 150 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-751-013
Recall number
D-751-013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L3727 Exp 6/1/13

Distribution pattern

Nationwide and PR

drug · product 61 of 105

Meloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-752-2013
Recall number
D-752-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5426 Exp 8/26/13 and A5110 Exp 12/1/13

Distribution pattern

Nationwide and PR

drug · product 62 of 105

Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL

D-753-2013
Recall number
D-753-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5021 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 63 of 105

Metabolase Injection, compounded by Olympia Pharmacy, Orlando, FL

D-754-2013
Recall number
D-754-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0101 Exp 10/31/13 and B0013 Exp 8/13/13

Distribution pattern

Nationwide and PR

drug · product 64 of 105

Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-755-2013
Recall number
D-755-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0001 Exp 8/1/13

Distribution pattern

Nationwide and PR

drug · product 65 of 105

Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-756-2013
Recall number
D-756-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L3326 Exp 6/30/13

Distribution pattern

Nationwide and PR

drug · product 66 of 105

Methylcobalamin 25 mg/ml Inj and 5000 mcg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-757-2013
Recall number
D-757-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

25mg/ml Inj Lot L3620 Exp 12/31/13 5000mcg/ml Inj Lot A3328 Exp 6/28/13

Distribution pattern

Nationwide and PR

drug · product 67 of 105

Methylprednisolone Acetate 80 mg/ml Injection, compounded by Olympia, FL

D-758-2013
Recall number
D-758-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A3104 Exp 6/4/13

Distribution pattern

Nationwide and PR

drug · product 68 of 105

Metoclopramide 5 mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL

D-759-2013
Recall number
D-759-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5423 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 69 of 105

MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 25/50/330 Inj, compounded by Olympia Pharmacy, Orlando, FL

D-760-2013
Recall number
D-760-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

Lots: L5306 Exp 11/30/13 and C5414 Exp 9/21/13 25/50/330 Lot L5118 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 70 of 105

Miconazole 3% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-761-2013
Recall number
D-761-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5001 Exp 6/1/13

Distribution pattern

Nationwide and PR

drug · product 71 of 105

Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-762-2013
Recall number
D-762-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

K5013 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 72 of 105

Neomycin / Polymyxin / Dexamethasone Ophthalmic Drops, compounded by Olympia Pharmacy, Orlando, FL

D-763-2013
Recall number
D-763-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5531 Exp 6/5/13

Distribution pattern

Nationwide and PR

drug · product 73 of 105

Oxytocin 20 units/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-764-2013
Recall number
D-764-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5019 Exp 10/31/13, B3525 Exp 8/25/13 and B3122 Exp 8/22/13

Distribution pattern

Nationwide and PR

drug · product 74 of 105

Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-765-2013
Recall number
D-765-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
6

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0021 Exp 8/31/13, B0013 Exp 8/1/13, C5122 Exp 9/22/13, C51101 Exp 8/1/13, C5508 Exp 9/8/13, and C5119 Exp 9/19/13

Distribution pattern

Nationwide and PR

drug · product 75 of 105

PEN-DEX-CHLOR Injection, compounded by Olympia Pharmacy, Orlando, FL

D-766-2013
Recall number
D-766-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5108 Exp 9/10/13

Distribution pattern

Nationwide and PR

drug · product 76 of 105

Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-767-2013
Recall number
D-767-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0521 Exp 8/21/13

Distribution pattern

Nationwide and PR

drug · product 77 of 105

Pentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-768-2013
Recall number
D-768-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

K5629 Exp 11/30/13, C51013 Exp 9/10/13 and C5513 Exp 9/14/13

Distribution pattern

Nationwide and PR

drug · product 78 of 105

Phenobarbital 62. 5mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-769-2013
Recall number
D-769-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5128 Exp 8/28/13

Distribution pattern

Nationwide and PR

drug · product 79 of 105

Phentolamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-770-2013
Recall number
D-770-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
5

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B31012 Exp 8/31/13, B5102 Exp 8/10/13, C5228 Exp 9/22/13, B5012 Exp 12/31/13, and C5111 exp 9/11/13

Distribution pattern

Nationwide and PR

drug · product 80 of 105

Phenylbutazone 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-771-2013
Recall number
D-771-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5224 Exp 8/1/13

Distribution pattern

Nationwide and PR

drug · product 81 of 105

Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-772-2013
Recall number
D-772-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
4

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5017 Exp 10/31/13, C51301 Exp 9/30/13, B5312 Exp 8/31/13, and A5209 Exp 11/01/13

Distribution pattern

Nationwide and PR

drug · product 82 of 105

Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL

D-773-2013
Recall number
D-773-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
6

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

0.75% Lot L5611 Exp 11/30/13 // 1% Lot b3001 Exp 6/19/13, B5014 Exp 8/14/13, and A5431 Exp 6/4/13 // 3% Lot A5808 Exp 12/31/13 // 10% Lot C5328 Exp 9/3/13

Distribution pattern

Nationwide and PR

drug · product 83 of 105

Potassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL

D-774-2013
Recall number
D-774-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

K5019 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 84 of 105

Praziquantel 56.8mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-775-2013
Recall number
D-775-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L3320 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 85 of 105

Progesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL

D-776-2013
Recall number
D-776-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5007 Exp 8/7/13

Distribution pattern

Nationwide and PR

drug · product 86 of 105

Progesterone EO 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-777-2013
Recall number
D-777-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L3126 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 87 of 105

Quadmix, compounded by Olympia Pharmacy, Orlando, FL

D-778-2013
Recall number
D-778-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C4526 Exp 9/4/13, B4125 exp 8/12/13, and B5014 exp 8/1/13

Distribution pattern

Nationwide and PR

drug · product 88 of 105

Sermorelin/GHRP 3 mg/3 mg vial, compounded by Olympia Pharmacy, Orlando, FL

D-779-2013
Recall number
D-779-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5811 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 89 of 105

Sodium Iodide 20% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-780-2013
Recall number
D-780-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5822 Exp 9/8/13

Distribution pattern

Nationwide and PR

drug · product 90 of 105

Sodium Salicylate 40% Injection, compounded by Olympia Pharmacy, Orlando, FL

D-781-2013
Recall number
D-781-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5020 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 91 of 105

Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounded by Olympia Pharmacy, Orlando, FL

D-782-2013
Recall number
D-782-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
10

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

0.125% Lot B3505 Exp 8/1/13 // 1% Lots C5001 Exp 9/30/13, C5406 Exp 9/4/13, and C5306 Exp 9/30/13 // 2.5% Lot C5101 Exp 9/30/13 // 3% Lots B5120 Exp 10/31/13, C5301 Exp 9/30/13, B5428 Exp 6/4/13, and C5212 Exp 9/21/13 // 4% Lot C5301 Exp 9/30/13

Distribution pattern

Nationwide and PR

drug · product 92 of 105

Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

D-783-2013
Recall number
D-783-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
3

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

50mg/ml = Lots B5727 Exp 8/27/13, and C5708 Exp 9/8/13 // 100,g/ml =Lot C5706 Exp 9/6/13

Distribution pattern

Nationwide and PR

drug · product 93 of 105

Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL

D-784-2013
Recall number
D-784-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C51012 Exp 9/12/13 and C51201 Exp 9/6/13

Distribution pattern

Nationwide and PR

drug · product 94 of 105

Taurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-785-2013
Recall number
D-785-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

C5629 Exp 10/31/13

Distribution pattern

Nationwide and PR

drug · product 95 of 105

Testosterone Cypionate (100 mg/ml & 200 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

D-786-2013
Recall number
D-786-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5016 Exp 12/31/13 and B5028 6/5/13

Distribution pattern

Nationwide and PR

drug · product 96 of 105

Trimix, compounded by Olympia Pharmacy, Orlando, FL

D-787-2013
Recall number
D-787-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
24

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020 Exp 6/1/13, B50112 Exp 8/11/13, C4186 Exp 6/18/13, C4158 Exp 6/15/13, C4149 Exp 6/14/13, C4111 Exp 6/11/13, B4124 Exp 8/12/13, B4154 Exp 8/15/13, B4198 Exp 8/19/13, B4226 Exp 8/22/13, B4268 Exp 8/22/13, C40522 Exp 9/5/13, C4118 Exp 9/1/13, C4711 Exp 9/7/13, C41121 Exp 9/11/13, C4126 Exp 9/12/13 and B42715 Exp 8/27/13.

Distribution pattern

Nationwide and PR

drug · product 97 of 105

Tripelennamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-788-2013
Recall number
D-788-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B5620 Exp 8/20/13 and A0322 Exp 12/31/13

Distribution pattern

Nationwide and PR

drug · product 98 of 105

Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL

D-789-2013
Recall number
D-789-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5011 Exp 7/10/13

Distribution pattern

Nationwide and PR

drug · product 99 of 105

Vitamin A/D3/E Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL

D-790-2013
Recall number
D-790-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5303 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 100 of 105

Vitamin B12 (3000 mcg/ml & 5000 mcg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

D-791-2013
Recall number
D-791-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
2

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0020 Exp 8/20/13 and C31011 Exp 9/10/13

Distribution pattern

Nationwide and PR

drug · product 101 of 105

Vitamin B12 Cyanocobalamin 5000 mcg Injection, compounded by Olympia Pharmacy, Orlando, FL

D-792-2013
Recall number
D-792-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

L5203 Exp 11/30/13

Distribution pattern

Nationwide and PR

drug · product 102 of 105

Vitamin B-Buildup Injection, compounded by Olympia Pharmacy, Orlando, FL

D-793-2013
Recall number
D-793-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

B0122 Exp 8/22/13

Distribution pattern

Nationwide and PR

drug · product 103 of 105

Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL

D-794-2013
Recall number
D-794-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5615 Exp 6/6/13

Distribution pattern

Nationwide and PR

drug · product 104 of 105

Xylazine 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-795-2013
Recall number
D-795-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5025 Exp 6/2/13

Distribution pattern

Nationwide and PR

drug · product 105 of 105

Yohimbine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

D-796-2013
Recall number
D-796-2013
Initiated
May 29, 2013
Classification
Class II
Status
Ongoing
Quantity
1

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Code information

A5008 Exp 12/31/13

Distribution pattern

Nationwide and PR